KSK-74: Dual Histamine H(3) and Sigma-2 Receptor Ligand with Anti-Obesity Potential

Many studies involving compounds that enhance histamine release, such as histamine H(3) receptor (H(3)R) antagonists, have shown efficacy in inhibiting weight gain, but none have passed clinical trials. As part of the search for H(3) receptor ligands that have additional properties, the aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Mika, Kamil, Szafarz, Małgorzata, Zadrożna, Monika, Nowak, Barbara, Bednarski, Marek, Szczepańska, Katarzyna, Pociecha, Krzysztof, Kubacka, Monika, Nicosia, Noemi, Juda, Izabela, Kieć-Kononowicz, Katarzyna, Kotańska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266460/
https://www.ncbi.nlm.nih.gov/pubmed/35806019
http://dx.doi.org/10.3390/ijms23137011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266460/
https://www.ncbi.nlm.nih.gov/pubmed/35806019
http://dx.doi.org/10.3390/ijms23137011

Ejemplares similares